Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mirtazapine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine measurement |
Component |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mirtazapine 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mirtazapine 15 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mirtazapine 30 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mirtazapine 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral mirtazapine tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral form mirtazapine disintegrating tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mirtazapine 45mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mirtazapine 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adverse reaction to mirtazapine |
Causative agent (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 45 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mirtazapine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 45 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 15 mg oral tablet |
Has precise active ingredient |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 30 mg oral tablet |
Has precise active ingredient |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 45 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only mirtazapine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only mirtazapine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 15 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 15 mg orodispersible tablet |
Has precise active ingredient |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 30 mg orodispersible tablet |
Has precise active ingredient |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine 30 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 45 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mirtazapine 45 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing mirtazapine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mirtazapine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mirtazapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |